94 related articles for article (PubMed ID: 8773348)
1. Population analysis of mesothelium in situ and in vivo exposed to bicarbonate-buffered peritoneal dialysis fluid.
Gotloib L; Wajsbrot V; Shostak A; Kushnier R
Nephron; 1996; 73(2):219-27. PubMed ID: 8773348
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose-enriched, lactated, buffered dialysis solutions.
Gotloib L; Waisbrut V; Shostak A; Kushnier R
Nephron; 1995; 70(4):466-77. PubMed ID: 7477654
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility of a glucose-free, acidic lactated solution for peritoneal dialysis evaluated by population analysis of mesothelium.
Wajsbrot V; Shostak A; Gotloib L; Kushnier R
Nephron; 1998; 79(3):322-32. PubMed ID: 9678434
[TBL] [Abstract][Full Text] [Related]
4. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis.
Haas S; Schmitt CP; Arbeiter K; Bonzel KE; Fischbach M; John U; Pieper AK; Schaub TP; Passlick-Deetjen J; Mehls O; Schaefer F
J Am Soc Nephrol; 2003 Oct; 14(10):2632-8. PubMed ID: 14514742
[TBL] [Abstract][Full Text] [Related]
5. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
6. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperosmolality upon the mesothelial monolayer exposed in vivo and in situ to a mannitol-enriched dialysis solution.
Gotloib L; Wajsbrot V; Shostak A; Kushnier R
Nephron; 1999; 81(3):301-9. PubMed ID: 10050085
[TBL] [Abstract][Full Text] [Related]
8. Dialysis solutions buffered with lactate or bicarbonate: in vitro comparison of two dialysis solutions on human peritoneal cell growth from ESRD and non-ESRD patients.
Fougeray S; Slingeneyer A; Bastide JM; Mion C; Bastide M
Adv Perit Dial; 1994; 10():235-40. PubMed ID: 7999836
[TBL] [Abstract][Full Text] [Related]
9. The cytochemical profile of visceral mesothelium under the influence of lactated-hyperosmolar peritoneal dialysis solutions.
Gotloib L; Shostak A; Wajsbrot V; Kuschnier R
Nephron; 1995; 69(4):466-71. PubMed ID: 7777114
[TBL] [Abstract][Full Text] [Related]
10. The influence of bicarbonate/lactate-buffered PD fluids on N{ε}-(carboxyethyl)lysine and N{ε}-(carboxymethyl)lysine in peritoneal effluent.
Cnossen TT; Gladziwa U; van de Kerkhof JJ; Schalkwijk CG; Scheijen J; van Amersfoort J; Moret K; Beerenhout CH; Kooman JP
Perit Dial Int; 2011; 31(2):189-93. PubMed ID: 20671103
[TBL] [Abstract][Full Text] [Related]
11. Effect of different buffers on the biocompatibility of CAPD solutions.
Schambye HT
Perit Dial Int; 1996; 16 Suppl 1():S130-6. PubMed ID: 8728179
[TBL] [Abstract][Full Text] [Related]
12. Effects of Icodextrin and Glucose Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids on Effluent Cell Population and Biocompatibility Markers IL-6 and CA125 in Incident Peritoneal Dialysis Patients.
Opatrná S; Pöpperlová A; Lysák D; Fuchsová R; Trefil L; Racek J; Topolčan O
Ther Apher Dial; 2016 Apr; 20(2):149-57. PubMed ID: 26929256
[TBL] [Abstract][Full Text] [Related]
13. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
14. Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion.
MacKenzie RK; Holmes CJ; Moseley A; Jenkins JP; Williams JD; Coles GA; Faict D; Topley N
J Am Soc Nephrol; 1998 Aug; 9(8):1499-506. PubMed ID: 9697673
[TBL] [Abstract][Full Text] [Related]
15. Bicarbonate buffered peritoneal dialysis fluid upregulates angiopoietin-1 and promotes vessel maturation.
Eich G; Bartosova M; Tischer C; Wlodkowski TT; Schaefer B; Pichl S; Kraewer N; Ranchin B; Vondrak K; Liebau MC; Hackert T; Schmitt CP
PLoS One; 2017; 12(12):e0189903. PubMed ID: 29253861
[TBL] [Abstract][Full Text] [Related]
16. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
Fusshoeller A; Plail M; Grabensee B; Plum J
Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
[TBL] [Abstract][Full Text] [Related]
17. Use of different buffers in peritoneal dialysis.
Feriani M
Semin Dial; 2000; 13(4):256-60. PubMed ID: 10923355
[TBL] [Abstract][Full Text] [Related]
18. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
19. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
[TBL] [Abstract][Full Text] [Related]
20. Mesothelial dysplastic changes and lipid peroxidation induced by 7.5% icodextrin.
Gotloib L; Wajsbrot V; Shostak A
Nephron; 2002 Sep; 92(1):142-55. PubMed ID: 12187097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
